On Oct 18, major Wall Street analysts update their ratings for $Equifax (EFX.US)$, with price targets ranging from $293 to $380.
Goldman Sachs analyst George Tong maintains with a hold rating, and adjusts the target price from $307 to $293.
Barclays analyst Manav Patnaik maintains with a buy rating, and maintains the target price at $380.
Wells Fargo analyst Jason Haas CFA maintains with a buy rating, and adjusts the target price from $375 to $350.
Oppenheimer analyst Owen Lau maintains with a buy rating, and maintains the target price at $315.
Needham analyst Kyle Peterson maintains with a buy rating, and maintains the target price at $350.
Furthermore, according to the comprehensive report, the opinions of $Equifax (EFX.US)$'s main analysts recently are as follows:
Equifax's third-quarter results were characterized as 'mixed,' with reported revenue and EBITDA margins slightly below estimates and consensus. Notably, a positive development emerged as mortgage inquiries during the third quarter showed year-over-year growth for the first time since 2021. This suggests a potential bottoming out of mortgage volumes, which could experience ongoing benefits from lower interest rates.
The firm considers the recent guidance reduction a modest negative, yet believes the company is on the brink of a significant multi-year period of earnings growth. The valuation is seen as appealing when adjusted for the mortgage cycle, and the company stands as the leading stock idea within the consumer credit information sector.
Here are the latest investment ratings and price targets for $Equifax (EFX.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月18日，多家华尔街大行更新了$艾可菲 (EFX.US)$的评级，目标价介于293美元至380美元。
高盛集团分析师George Tong维持持有评级，并将目标价从307美元下调至293美元。
巴克莱银行分析师Manav Patnaik维持买入评级，维持目标价380美元。
富国集团分析师Jason Haas CFA维持买入评级，并将目标价从375美元下调至350美元。
奥本海默控股分析师Owen Lau维持买入评级，维持目标价315美元。
Needham分析师Kyle Peterson维持买入评级，维持目标价350美元。
此外，综合报道，$艾可菲 (EFX.US)$近期主要分析师观点如下：
艾可菲的第三季度业绩被描述为'混合的'，报告的营业收入和EBITDA利润率略低于估计和共识。值得注意的是，积极的发展是，第三季度的抵押贷款查询首次自2021年以来呈现了同比增长。这表明抵押贷款量有可能触底，受益于较低的利率期货，未来可能会持续受益。
公司认为最近的指导降低是一个轻微的负面，但认为公司正处于一个重要的多年盈利增长期。在调整抵押贷款周期后，估值被视为吸引人，该公司被视为消费信贷信息板块中的领先股票概念。
以下为今日6位分析师对$艾可菲 (EFX.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
